Does Dr. ERIN BUCZEK have financial conflicts of interest?

Dr. ERIN BUCZEK (MD) has received a total of $197 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $197 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ERIN BUCZEK?

According to CMS Open Payments data, Dr. ERIN BUCZEK received funding from INTEGRA LIFESCIENCES CORPORATION ($169), AXOGEN ($14), and GALDERMA LABORATORIES, L.P ($13).

Does Dr. ERIN BUCZEK receive research grants or speaking fees?

Dr. ERIN BUCZEK has received $197 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ERIN BUCZEK

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: KANSAS CITY, KS 66160

NPI Number: 1215227350

LIFETIME INDUSTRY VALUE

$197

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BUCZEK is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in KANSAS CITY, KS.

Between 2021 and 2024, Dr. BUCZEK had an overall industry promotional and research financial footprint of $197 as recorded in the federal CMS Open Payments database.

$197 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BUCZEK's primary funding source is INTEGRA LIFESCIENCES CORPORATION, which accounts for $169 (representing 86% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INTEGRA LIFESCIENCES CORPORATION

Rank 1

$169

86%

AXOGEN

Rank 2

$14

7.2%

GALDERMA LABORATORIES, L.P

Rank 3

$13

6.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.